×
For best experience we recommend to activate Javascript in your browser.
DDR1 antibody (AA 568-829)
The Rabbit Polyclonal anti-DDR1 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect DDR1 in samples from Human.
Quick Overview for DDR1 antibody (AA 568-829) (ABIN7616117)
Target
See all DDR1 Antibodies
DDR1
(Discoidin Domain Receptor tyrosine Kinase 1 (DDR1))
Reactivity
All reactivities for DDR1 antibodies
Human
Host
All hosts for DDR1 antibodies
Rabbit
Clonality
All clonalities for DDR1 antibodies
Polyclonal
Conjugate
All conjugates for DDR1 antibodies
This DDR1 antibody is un-conjugated
Application
All applications for DDR1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-DDR1 Antibody
(hide)
Binding Specificity
All epitopes for DDR1 antibodies
AA 568-829
Purpose
Discoidin Domain Receptor Family, Member 1 (DDR1) Polyclonal Antibody
Sequence
His568~Phe829
Characteristics
The Discoidin Domain Receptor Family, Member 1 (DDR1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for DDR1
(hide)
Target
DDR1
(Discoidin Domain Receptor tyrosine Kinase 1 (DDR1))
Alternative Name
DDR1
Gene ID
780
UniProt
Q08345
Pathways
RTK Signaling , Smooth Muscle Cell Migration
Recently viewed
(hide)
Chat with us , powered by LiveChat